EMA
approval
· 2020-03-27
New gene therapy to treat spinal muscular atrophy (corrected)
Summary
The EMA announces a new gene therapy for spinal muscular atrophy, marking a significant regulatory milestone for treatment of the disease.
Upgrade for the full analysis, importance score, and drug timeline.